Skip to Main content Skip to Navigation
Journal articles

Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.

Abstract : In patients with cystic fibrosis (CF), rib and thoracic vertebral fractures can have adverse effects on lung health because the resulting pain and debilitation can impair airway clearance. The F508del mutation in the CF transmembrane conductance regulator (Cftr) gene induces an osteopenic phenotype in humans and mice. N-butyldeoxynojyrimicin (miglustat), an approved drug for treating type 1 Gaucher disease, was found to normalize CFTR-dependent chloride transport in human F508del CFTR lung cells and in nasal mucosa of F508del CF mice. Herein, we investigated whether targeting F508del-CFTR may rescue the skeletal osteopenic phenotype in murine CF. We found that oral administration of low-dose miglustat (120 mg/kg once a day for 28 days) improved bone mass and microarchitecture in the lumbar spine and femur in F508del mice. The increased bone density was associated with an increased bone formation rate and reduced bone resorption. This effect was associated with increased 17β-estradiol but not with insulin-like growth factor 1 serum levels in miglustat-treated F508del mice. Exposure of primary F508del osteoblasts to miglustat partially restored the deficient CFTR-dependent chloride transport in these bone-forming cells. This study provides evidence that reversal of CFTR-dependent chloride transport in osteoblasts normalizes bone mass and microarchitecture in murine CF. These findings may provide a potential therapeutic strategy to prevent or correct the bone disease in patients with CF.
Document type :
Journal articles
Complete list of metadatas

Cited literature [53 references]  Display  Hide  Download

https://www.hal.inserm.fr/inserm-00994801
Contributor : Jacky Jacquot <>
Submitted on : Thursday, May 22, 2014 - 10:45:55 AM
Last modification on : Friday, March 27, 2020 - 2:57:28 AM
Long-term archiving on: : Tuesday, April 11, 2017 - 1:09:06 AM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Carole Le Henaff, Eric Hay, Frederic Velard, Caroline Marty, Olivier Tabary, et al.. Enhanced F508del-CFTR channel activity ameliorates bone pathology in murine cystic fibrosis.. American Journal of Pathology, American Society for Investigative Pathology, 2014, 184 (4), pp.1132-41. ⟨10.1016/j.ajpath.2013.12.027⟩. ⟨inserm-00994801⟩

Share

Metrics

Record views

893